Your browser doesn't support javascript.
loading
Genetic landscape of homologous recombination repair genes in early-onset/familial prostate cancer patients.
Paulo, Paula; Cardoso, Marta; Brandão, Andreia; Pinto, Pedro; Falconi, Ariane; Pinheiro, Manuela; Cerveira, Nuno; Silva, Rui; Santos, Catarina; Pinto, Carla; Peixoto, Ana; Maia, Sofia; Teixeira, Manuel R.
Affiliation
  • Paulo P; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP) /RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) /Porto Comprehensive Cancer Center, Porto, Portugal.
  • Cardoso M; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP) /RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) /Porto Comprehensive Cancer Center, Porto, Portugal.
  • Brandão A; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP) /RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) /Porto Comprehensive Cancer Center, Porto, Portugal.
  • Pinto P; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP) /RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) /Porto Comprehensive Cancer Center, Porto, Portugal.
  • Falconi A; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP) /RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) /Porto Comprehensive Cancer Center, Porto, Portugal.
  • Pinheiro M; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP) /RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) /Porto Comprehensive Cancer Center, Porto, Portugal.
  • Cerveira N; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP) /RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) /Porto Comprehensive Cancer Center, Porto, Portugal.
  • Silva R; Department of Laboratory Genetics, Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center, Porto, Portugal.
  • Santos C; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP) /RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) /Porto Comprehensive Cancer Center, Porto, Portugal.
  • Pinto C; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP) /RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) /Porto Comprehensive Cancer Center, Porto, Portugal.
  • Peixoto A; Department of Laboratory Genetics, Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center, Porto, Portugal.
  • Maia S; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP) /RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) /Porto Comprehensive Cancer Center, Porto, Portugal.
  • Teixeira MR; Department of Laboratory Genetics, Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center, Porto, Portugal.
Genes Chromosomes Cancer ; 62(12): 710-720, 2023 12.
Article de En | MEDLINE | ID: mdl-37436117

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la prostate / Tumeurs du sein / Carcinomes Limites: Humans / Male Langue: En Journal: Genes Chromosomes Cancer Sujet du journal: BIOLOGIA MOLECULAR / NEOPLASIAS Année: 2023 Type de document: Article Pays d'affiliation: Portugal Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la prostate / Tumeurs du sein / Carcinomes Limites: Humans / Male Langue: En Journal: Genes Chromosomes Cancer Sujet du journal: BIOLOGIA MOLECULAR / NEOPLASIAS Année: 2023 Type de document: Article Pays d'affiliation: Portugal Pays de publication: États-Unis d'Amérique